Abstract:Objectives: To determine how plasma fibrinogen levels impact the severity of microvascular complications in people with type 2 diabetes while focussing on the molecular mechanisms of fibrinogen's role in such complications. Methods: The analytical, cross-sectional study was conducted from September 2022 to March 2023 at the Department of Medicine, Mardan Medical Complex and Teaching Hospital, Khyber Pakhtunkhwa, Pakistan, and comprised adult patients of either gender who had been diagnosed with type 2 diabetes and microvascular complications. Each patient was subjected to an evaluation of microvascular complications, including diabetic retinopathy, nephropathy and neuropathy, using validated diagnostic criteria and clinical examinations. Data was analysed using SPSS 26. Results: Of the 174 patients 97(%) were males and 77(%) were females. Retinopathy was found in 57(32.7) patients with median age 53 years (interquartile range: 46-63 years). Nephropathy was found in 55(31.6%) subjects with median age 54 years (interquartile range: 50-61 years). Neuropathy was found in 62(35.6%) patients with median age 53 years (interquartile range: 48-58 years). Diabetic neuropathy was significantly associated with elevated plasma fibrinogen levels and various biomarkers, such as creatinine, urea, fasting blood glucose, glycated haemoglobin and estimated average glucose (p<0.05). Diabetic retinopathy was significantly linked with higher levels of fibrinogen, which manifested through symptoms, like floaters or dark spots, impaired colour vision, difficulty seeing at night, blurred or fluctuating vision and vision loss (p<0.05). Diabetic nephropathy and the progression of its severity was significantly associated with increased fibrinogen levels, as well as markers, like albuminuria, creatinine, urea, fasting blood glucose, glycated haemoglobin and estimated average glucose (p<0.05). Conclusions: Elevated plasma fibrinogen levels in patients with type 2 diabetes significantly correlated with increased microvascular complications, underscoring the importance of monitoring and managing fibrinogen levels to mitigate diabetes-associated vascular pathologies.

Fibrinogen is a Predictor for Progressive Proteinuria in Type 2 Diabetes

Relationship between fibrinogen and microalbuminuria in elderly patients with type 2 diabetes mellitus

Urinary Fibrinogen As a Predictor of Progression of CKD

Serum fibrinogen predicts diabetic ESRD in patients with type 2 diabetes mellitus.

Levels of Inflammatory Cytokines in Type 2 Diabetes Patients with Different Urinary Albumin Excretion Rates and Their Correlation with Clinical Variables

Association of altered fibrinogen indexes levels as a potential biomarker in determining the possible onset of diabetic retinopathy

The Clinical Significance of Plasma Fibronectin, Urinary Fibronectin and Urinary Transferrin in Type 2 Diabetics

Risk factors of early progressive renal function decline in type 2 diabetes mellitus patients

The Predictive Value of Fibrinogen in the Occurrence of Mild Cognitive Impairment Events in Patients with Diabetic Peripheral Neuropathy

Role of serum β2-microglobulin, glycosylated hemoglobin, and vascular endothelial growth factor levels in diabetic nephropathy

Association of coagulation and fibrinolysis with microalbuminuria in patients with essential hypertensive

Correlation between plasma fibrinogen levels and microvascular complications in type 2 diabetes

The Relationship Between Changes of Plasma Fibrinolysis and Coagulation Parameters and Type 2 Diabetic Microangiopathy

The changes of serum intact fibroblast growth factor 23 in type 2 diabetes patients with different phases of diabetic nephropathy

Coagulation Function and Type 2 Diabetic Kidney Disease: A Real-World Observational Study

Association Between Serum Fibroblast Growth Factor 21 and Diabetic Nephropathy.

Clinical significance of urinary Alpha-1 acid glycoprotein in predicting the progression of diabetic nephropathy in type 2 diabetic patients

Increased Urinary Angiotensinogen Precedes the Onset of Albuminuria in Normotensive Type 2 Diabetic Patients.

Evaluation of urinary L-FABP as an early marker for diabetic nephropathy in type 2 diabetic patients

Impaired fasting blood glucose is associated with incident albuminuria: Data from a Chinese community-based cohort

FABP1 and FABP2 as markers of diabetic nephropathy